Cardiovascular Pacing and ICD Leads Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Cardiovascular Pacing and ICD Leads Pipeline Market Report Overview

Cardiovascular pacing and ICD lead is an implantable cardioverter defibrillator (ICD) that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia and restores the heart’s natural rhythm.

The cardiovascular pacing and ICD leads pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       United States

·       Europe

·       China

·       Japan

Key Regulatory Paths ·       PMA

·       CE

·       NMPA

·       Ninsho

·       510(k)

Leading Companies ·       APT Medical Inc

·       AtaCor Medical Inc

·       Biotronik SE & Co KG

·       Boston Scientific Corp

·       Endomimetics LLC

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Cardiovascular Pacing and ICD Leads Pipeline Market Segmentation by Territories

A few of the key territories with the cardiovascular pacing and ICD leads pipeline market are the US, China, Europe, Japan, and Global. As of October 2024, the US accounted for the highest number of pipeline products.

Cardiovascular Pacing and ICD Leads Pipeline Market Analysis by Territories, 2024 (%)

Cardiovascular Pacing and ICD Leads Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Cardiovascular Pacing and ICD Leads Pipeline Market or Download a Free Report Sample

Cardiovascular Pacing and ICD Leads Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the cardiovascular pacing and ICD leads pipeline products market are PMA, CE, NMPA, Ninsho, and 510(k). As of October 2024, PMA was the most followed pathway for pipeline products in the cardiovascular pacing and ICD leads market.

Cardiovascular Pacing and ICD Leads Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Cardiovascular Pacing and ICD Leads Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Cardiovascular Pacing and ICD Leads Pipeline Market or Download a Free Report Sample

Cardiovascular Pacing and ICD Leads Pipeline Market – Competitive Landscape

A few of the key companies associated with the cardiovascular pacing and ICD leads pipeline market are APT Medical Inc, AtaCor Medical Inc, Biotronik SE & Co KG, Boston Scientific Corp, Endomimetics LLC, and others.

Biotronik SE & Co KG: Headquartered in Berlin, Germany, this medical device company develops, manufactures, and distributes cardiovascular and endovascular solutions. The company’s cardiac rhythm management solutions include implantable devices, leads, accessories, and external devices to treat and manage arrhythmia-related diseases.

Boston Scientific Corp: Headquartered in Marlborough, Massachusetts, the US, this medical technology company develops, manufactures, and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, and others.

Cardiovascular Pacing and ICD Leads Pipeline Market Analysis by Companies, 2024

Cardiovascular Pacing and ICD Leads Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the CARDIOVASCULAR PACING AND ICD LEADS Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Cardiovascular Pacing and ICD Leads Pipeline Market Territories Outlook (2024)

  • United States
  • Europe
  • China
  • Japan
  • Global

Cardiovascular Pacing and ICD Leads Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • NMPA
  • Ninsho
  • 510(k)

Scope

This report provides:

  • Extensive coverage of the cardiovascular pacing and ICD leads under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of cardiovascular pacing and ICD leads and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of cardiovascular pacing and ICD leads under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

APT Medical Inc
AtaCor Medical Inc
Biotronik SE & Co KG
Boston Scientific Corp
Endomimetics LLC
Mayo Clinic
Medtronic Plc
MicroPort CRM SA
MicroPort Scientific Corp
St. Jude Medical LLC
Teleflex Inc

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Cardiovascular Pacing and ICD Leads Overview

3 Products under Development

3.1 Cardiovascular Pacing and ICD Leads – Pipeline Products by Stage of Development

3.2 Cardiovascular Pacing and ICD Leads – Pipeline Products by Territory

3.3 Cardiovascular Pacing and ICD Leads – Pipeline Products by Regulatory Path

3.4 Cardiovascular Pacing and ICD Leads – Pipeline Products by Estimated Approval Date

3.5 Cardiovascular Pacing and ICD Leads – Ongoing Clinical Trials

4 Cardiovascular Pacing and ICD Leads – Pipeline Products under Development by Companies

4.1 Cardiovascular Pacing and ICD Leads Companies – Pipeline Products by Stage of Development

4.2 Cardiovascular Pacing and ICD Leads – Pipeline Products by Stage of Development

5 Cardiovascular Pacing and ICD Leads Companies and Product Overview

5.1 APT Medical Inc Company Overview

5.1.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 AtaCor Medical Inc Company Overview

5.2.1 AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 Biotronik SE & Co KG Company Overview

5.3.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview

5.4 Boston Scientific Corp Company Overview

5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.5 Endomimetics LLC Company Overview

5.5.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.6 Mayo Clinic Company Overview

5.6.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview

5.7 Medtronic Plc Company Overview

5.7.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

5.8 MicroPort CRM SA Company Overview

5.8.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview

5.9 MicroPort Scientific Corp Company Overview

5.9.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.10 St. Jude Medical LLC Company Overview

5.10.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.11 Teleflex Inc Company Overview

5.11.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Cardiovascular Pacing and ICD Leads- Recent Developments

6.1 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results

6.2 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024

6.3 Sep 25, 2024: LivaNova to Announce Third-Quarter 2024 Results

6.4 Sep 17, 2024: Boston Scientific Receives FDA Approval for Expanded Indication of INGEVITY+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area

6.5 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024

6.6 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.7 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.8 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.9 May 17, 2024: Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure

6.10 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.11 Mar 04, 2024: LivaNova to Present at the Barclays Global Healthcare Conference

6.12 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company

6.13 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering

6.14 Feb 18, 2024: MicroPort CRM AAnnounces the Launch of GALI SonR CRT-D and NAVIGO 4LV left ventricular pacing leads in Japan

6.15 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Cardiovascular Pacing and ICD Leads – Pipeline Products by Stage of Development

Cardiovascular Pacing and ICD Leads – Pipeline Products by Territory

Cardiovascular Pacing and ICD Leads – Pipeline Products by Regulatory Path

Cardiovascular Pacing and ICD Leads – Pipeline Products by Estimated Approval Date

Cardiovascular Pacing and ICD Leads – Ongoing Clinical Trials

Cardiovascular Pacing and ICD Leads Companies – Pipeline Products by Stage of Development

Cardiovascular Pacing and ICD Leads – Pipeline Products by Stage of Development

APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Mapping Lead – Product Status

Mapping Lead – Product Description

AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Extracardiac Pacing Lead – Product Status

Extracardiac Pacing Lead – Product Description

Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview

Cardiac Conduction System – Product Status

Cardiac Conduction System – Product Description

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

MRI-Safe Implantable Cardiac Rhythm Management Lead – Product Status

MRI-Safe Implantable Cardiac Rhythm Management Lead – Product Description

Next Generation ICD Lead – Product Status

Next Generation ICD Lead – Product Description

X4 System + Quad Lead – Product Status

X4 System + Quad Lead – Product Description

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

Pacemaker Lead – Product Status

Pacemaker Lead – Product Description

Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview

Epicardial Pacing/Sensing Lead – Product Status

Epicardial Pacing/Sensing Lead – Product Description

Pacemaker/ICD Lead – Product Status

Pacemaker/ICD Lead – Product Description

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

OmniaSecure – Product Status

OmniaSecure – Product Description

MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview

Axone 4LV Lead – Product Status

Axone 4LV Lead – Product Description

BonaFire – Active Pacing Lead – Product Status

BonaFire – Active Pacing Lead – Product Description

BonaFire – Passive Pacing Lead – Product Status

BonaFire – Passive Pacing Lead – Product Description

Nano Lead System – Product Status

Nano Lead System – Product Description

SonR Tist Lead Positioning – Product Status

SonR Tist Lead Positioning – Product Description

Tachy Lead – Product Status

Tachy Lead – Product Description

TX Brady Lead – Product Status

TX Brady Lead – Product Description

Vega 1.5/3T Pacemaker – Product Status

Vega 1.5/3T Pacemaker – Product Description

MicroPort CRM SA – Ongoing Clinical Trials Overview

Axone 4LV Lead – Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

30M (MRI Pacing Lead) – Product Status

30M (MRI Pacing Lead) – Product Description

LBB (MRI Pacing Lead) – Product Status

LBB (MRI Pacing Lead) – Product Description

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

Quartet NXT – Double Bend Lead – Product Status

Quartet NXT – Double Bend Lead – Product Description

Quartet NXT – Large S-Curve Lead – Product Status

Quartet NXT – Large S-Curve Lead – Product Description

Quartet NXT – Small S-Curve Lead – Product Status

Quartet NXT – Small S-Curve Lead – Product Description

Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview

Pacemaker Lead – Product Status

Pacemaker Lead – Product Description

Glossary

Figures

Cardiovascular Pacing and ICD Leads – Pipeline Products by Stage of Development

Cardiovascular Pacing and ICD Leads – Pipeline Products by Territory

Cardiovascular Pacing and ICD Leads – Pipeline Products by Regulatory Path

Cardiovascular Pacing and ICD Leads – Pipeline Products by Estimated Approval Date

Cardiovascular Pacing and ICD Leads – Ongoing Clinical Trials

Frequently asked questions

Cardiovascular Pacing and ICD Leads Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Cardiovascular Pacing and ICD Leads Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cardiovascular Pacing and ICD Leads Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Cardiovascular Pacing and ICD Leads Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.